SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-04-14 14:09
Tx date 2025-03-31 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-350,000
-43,750 vol
$8.00 each 		263,750
Filed 2025-03-27 14:10
Tx date 2025-03-25 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$231,300
+45,000 vol
$5.14 each 		307,500
Filed 2024-05-22 23:33
Tx date 2024-05-13 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$178,200
+45,000 vol
$3.96 each 		262,500
Filed 2024-01-12 16:35
Tx date 2024-01-12 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Holder: Dr. Simon Pimstone Inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership 		$28,000
+4,000 vol
$7.00 each 		4,000
Filed 2024-01-12 16:34
Tx date 2021-03-03 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Holder: Dr. Simon Pimstone Inc. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-01-12 16:33
Tx date 2024-01-12 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership 		$-28,000
-4,000 vol
$7.00 each 		4,626
Filed 2023-08-20 11:31
Tx date 2023-08-18 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$28,000
+4,000 vol
$7.00 each 		8,626
Filed 2023-06-05 13:30
Tx date 2023-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$719,786
+18,475 vol
$38.96 each 		1,218,157
Filed 2023-06-02 18:02
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-940,608.90
-24,255 vol
$38.78 each 		6,000
Filed 2023-06-02 18:01
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-799,304.85
-20,745 vol
$38.53 each 		30,255
Filed 2023-06-02 17:59
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$799,200
+45,000 vol
$17.76 each 		51,000
Filed 2023-06-02 17:58
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-799,200
-45,000 vol
$17.76 each 		1,199,682
Filed 2023-06-02 17:56
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-290,638.26
-7,458 vol
$38.97 each 		6,000
Filed 2023-06-02 17:55
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$-71,665.80
-1,860 vol
$38.53 each 		13,458
Filed 2023-06-02 17:49
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-71,655.42
-9,318 vol
$7.69 each 		1,244,682
Filed 2023-06-02 17:46
Tx date 2023-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$71,655
+9,318 vol
$7.69 each 		15,318
Filed 2023-06-02 17:45
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,039,058.64
-26,856 vol
$38.69 each 		6,000
Filed 2023-06-02 17:42
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$-888,035.28
-23,144 vol
$38.37 each 		32,856
Filed 2023-06-02 17:41
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$888,000
+50,000 vol
$17.76 each 		56,000
Filed 2023-06-02 17:39
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-888,000
-50,000 vol
$17.76 each 		1,254,000
Filed 2023-06-02 17:34
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-918,632.70
-23,670 vol
$38.81 each 		6,000
Filed 2023-06-02 17:32
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase 		$-236,551.05
-6,165 vol
$38.37 each 		29,670
Filed 2023-06-02 17:29
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$293,874
+29,835 vol
$9.85 each 		35,835
Filed 2023-06-02 17:26
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-293,874.75
-29,835 vol
$9.85 each 		1,304,000
Filed 2023-06-02 17:13
Tx date 2023-05-31 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-462,360
-12,000 vol
$38.53 each 		6,000
Filed 2023-06-02 17:11
Tx date 2023-05-30 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-758,100
-19,000 vol
$39.90 each 		18,000
Filed 2023-06-02 17:09
Tx date 2023-05-30 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-695,571.78
-18,006 vol
$38.63 each 		37,000
Filed 2023-03-09 19:02
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-304,459.48
-8,242 vol
$36.94 each 		55,006
Filed 2023-03-09 19:01
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,618 vol 		63,248
Filed 2023-03-09 19:01
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+30,864 vol 		64,866
Filed 2023-03-09 19:00
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-406,739.90
-10,990 vol
$37.01 each 		34,002
Filed 2023-03-09 18:59
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-2,160 vol 		44,992
Filed 2023-03-09 18:58
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
+41,152 vol 		47,152
Filed 2023-03-09 18:55
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-79,937.76
-30,864 vol
$2.59 each 		1,333,835
Filed 2023-03-09 18:54
Tx date 2023-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-110,287.36
-41,152 vol
$2.68 each 		1,364,699
Filed 2022-12-12 20:05
Tx date 2022-12-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$57,750
+15,000 vol
$3.85 each 		217,500
Filed 2022-08-16 17:54
Tx date 2022-08-16 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-777,400
-20,000 vol
$38.87 each 		6,000
Filed 2022-08-16 17:53
Tx date 2022-08-16 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,227,500.82
-32,058 vol
$38.29 each 		26,000
Filed 2022-08-16 17:53
Tx date 2022-08-15 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,281,649.92
-33,942 vol
$37.76 each 		58,058
Filed 2022-08-16 17:52
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-39,150
-1,000 vol
$39.15 each 		92,000
Filed 2022-08-16 17:51
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,814,200
-47,000 vol
$38.60 each 		93,000
Filed 2022-08-16 17:50
Tx date 2022-08-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,635,247.85
-43,135 vol
$37.91 each 		140,000
Filed 2022-06-29 18:56
Tx date 2022-06-28 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$541,980
+18,000 vol
$30.11 each 		1,405,851
Filed 2022-03-14 16:34
Tx date 2022-03-10 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+25,000 vol 		1,387,851
Filed 2022-03-08 22:04
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,250
-2,500 vol
$30.50 each 		183,135
Filed 2022-03-08 22:03
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,375
-2,500 vol
$30.55 each 		185,635
Filed 2022-03-08 22:02
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-75,500
-2,500 vol
$30.20 each 		188,135
Filed 2022-03-08 22:02
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-75,250
-2,500 vol
$30.10 each 		190,635
Filed 2022-03-08 22:01
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-77,000
-2,500 vol
$30.80 each 		193,135
Filed 2022-03-08 22:01
Tx date 2022-03-08 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-62,760.60
-2,051 vol
$30.60 each 		195,635
Filed 2022-03-08 22:00
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,375
-2,500 vol
$30.55 each 		197,686
Filed 2022-03-08 22:00
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-228,750
-7,500 vol
$30.50 each 		200,186
Filed 2022-03-08 21:59
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-76,300
-2,500 vol
$30.52 each 		207,686
Filed 2022-03-08 21:59
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-137,467.04
-4,516 vol
$30.44 each 		210,186
Filed 2022-03-08 21:58
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-137,512.20
-4,516 vol
$30.45 each 		214,702
Filed 2022-03-08 21:57
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-137,723.33
-4,517 vol
$30.49 each 		219,218
Filed 2022-03-08 21:57
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-154,132.20
-5,037 vol
$30.60 each 		223,735
Filed 2022-03-08 21:56
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,990 vol 		228,772
Filed 2022-03-08 21:55
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$76,954
+20,576 vol
$3.74 each 		230,762
Filed 2022-03-08 21:55
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-146,474.08
-4,793 vol
$30.56 each 		210,186
Filed 2022-03-08 21:54
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-138,951.12
-4,532 vol
$30.66 each 		214,979
Filed 2022-03-08 21:53
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-963 vol 		219,511
Filed 2022-03-08 21:53
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$38,477
+10,288 vol
$3.74 each 		220,474
Filed 2022-03-08 21:52
Tx date 2022-03-07 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-76,954.24
-20,576 vol
$3.74 each 		1,362,851
Filed 2022-03-08 21:51
Tx date 2022-03-04 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-38,477.12
-10,288 vol
$3.74 each 		1,383,427
Filed 2021-12-13 16:19
Tx date 2021-12-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$20,200
+10,000 vol
$2.02 each 		202,500
Filed 2021-11-16 20:58
Tx date 2021-11-15 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-550,060.81
-17,557 vol
$31.33 each 		210,186
Filed 2021-05-26 16:25
Tx date 2021-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-5,076 vol 		227,743
Filed 2021-05-26 16:23
Tx date 2021-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$84,647
+22,633 vol
$3.74 each 		232,819
Filed 2021-05-26 16:22
Tx date 2021-05-24 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-84,647.42
-22,633 vol
$3.74 each 		1,393,715
Filed 2021-03-15 16:58
Tx date 2021-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+225,000 vol 		1,416,348
Filed 2021-03-12 13:40
Tx date 2021-03-03 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report 		125,000
Filed 2021-03-12 13:38
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
15 - Acquisition or disposition under a prospectus 		$440,000
+55,000 vol
$8.00 each 		192,500
Filed 2021-03-12 13:34
Tx date 2021-03-03 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		137,500
Filed 2021-03-12 13:34
Tx date 2021-03-03 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		4,626
Filed 2020-08-25 20:20
Tx date 2020-08-20 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Holder: Kanya Adam (Indirect Ownership)
Common Shares
97 - Other
-16,460 vol 		0
Filed 2020-08-24 18:47
Tx date 2020-08-20 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
-45,000 vol 		210,186
Filed 2020-06-02 19:26
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-43,290
-3,000 vol
$14.43 each 		255,186
Filed 2020-06-02 19:24
Tx date 2020-05-29 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-69,950
-5,000 vol
$13.99 each 		258,186
Filed 2020-05-28 20:30
Tx date 2020-05-26 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
-1,108 vol 		263,186
Filed 2020-05-28 20:28
Tx date 2020-05-26 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$23,083
+6,172 vol
$3.74 each 		264,294
Filed 2020-05-28 20:26
Tx date 2020-05-26 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-23,083.28
-6,172 vol
$3.74 each 		1,191,348
Filed 2020-03-16 16:37
Tx date 2020-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+280,000 vol 		1,197,520
Filed 2019-09-24 18:26
Tx date 2019-09-20 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-98,856.45
-10,395 vol
$9.51 each 		258,122
Filed 2019-09-19 19:38
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,643,200
+280,000 vol
$9.44 each 		975,132
Filed 2019-09-19 19:35
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$32,362
+8,653 vol
$3.74 each 		268,517
Filed 2019-09-19 19:34
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-3,692 vol 		917,520
Filed 2019-09-19 19:33
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-32,362.22
-8,653 vol
$3.74 each 		921,212
Filed 2019-09-19 19:32
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,272
+6,490 vol
$3.74 each 		259,864
Filed 2019-09-19 19:31
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-2,769 vol 		929,865
Filed 2019-09-19 19:30
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-24,272.60
-6,490 vol
$3.74 each 		932,634
Filed 2019-09-19 19:29
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$94,393
+25,239 vol
$3.74 each 		253,374
Filed 2019-09-19 19:27
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-10,769 vol 		939,124
Filed 2019-09-19 19:26
Tx date 2019-09-17 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-94,393.86
-25,239 vol
$3.74 each 		949,893
Filed 2018-03-14
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-38,477.12
-10,288 vol
$3.74 each 		695,132
Filed 2018-03-14
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$38,477
+10,288 vol
$3.74 each 		228,135
Filed 2018-03-13
Tx date 2018-03-12 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		705,420
Filed 2017-10-24
Tx date 2017-10-23 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+11,000 vol 		565,420
Filed 2017-08-14
Tx date 2017-08-10 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$17,400
+6,000 vol
$2.90 each 		217,847
Filed 2017-03-14
Tx date 2017-03-13 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+140,000 vol 		554,420
Filed 2016-08-02
Tx date 2016-07-29 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$28,581
+7,642 vol
$3.74 each 		211,847
Filed 2016-08-02
Tx date 2016-07-29 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-12,345 vol 		414,420
Filed 2016-03-11
Tx date 2016-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+50,000 vol 		426,765
Filed 2015-12-21
Tx date 2015-12-18 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		376,765
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$72,220
+11,898 vol
$6.07 each 		204,205
Filed 2015-08-20
Tx date 2015-08-18 		$XENE
Xenon Pharmaceuticals Inc. 		Pimstone, Simon Neil
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-20,576 vol 		336,765